Thiopilocarpine
Alternative Names: SDZ ENS 163Latest Information Update: 22 Jan 1997
At a glance
- Originator Novartis
- Class Nootropics
- Mechanism of Action Muscarinic M1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease